JPWO2022144911A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022144911A5 JPWO2022144911A5 JP2023533312A JP2023533312A JPWO2022144911A5 JP WO2022144911 A5 JPWO2022144911 A5 JP WO2022144911A5 JP 2023533312 A JP2023533312 A JP 2023533312A JP 2023533312 A JP2023533312 A JP 2023533312A JP WO2022144911 A5 JPWO2022144911 A5 JP WO2022144911A5
- Authority
- JP
- Japan
- Prior art keywords
- anhydride
- formula
- substituted
- compound
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims description 21
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical group CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 claims description 12
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 claims description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N dimethyl sulfoxide Natural products CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 5
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 claims description 2
- 238000000034 method Methods 0.000 claims 20
- 125000004432 carbon atom Chemical group C* 0.000 claims 11
- 125000000217 alkyl group Chemical group 0.000 claims 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 6
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 claims 4
- 238000007254 oxidation reaction Methods 0.000 claims 4
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims 3
- 229960000583 acetic acid Drugs 0.000 claims 3
- 125000003118 aryl group Chemical group 0.000 claims 3
- 239000012362 glacial acetic acid Substances 0.000 claims 3
- 239000007800 oxidant agent Substances 0.000 claims 3
- LJGHYPLBDBRCRZ-UHFFFAOYSA-N 3-(3-aminophenyl)sulfonylaniline Chemical compound NC1=CC=CC(S(=O)(=O)C=2C=C(N)C=CC=2)=C1 LJGHYPLBDBRCRZ-UHFFFAOYSA-N 0.000 claims 2
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical group N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 claims 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims 2
- HLMSIZPQBSYUNL-IPOQPSJVSA-N Noroxymorphone Chemical compound O=C([C@@H]1O2)CC[C@@]3(O)[C@H]4CC5=CC=C(O)C2=C5[C@@]13CCN4 HLMSIZPQBSYUNL-IPOQPSJVSA-N 0.000 claims 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims 2
- 239000003054 catalyst Substances 0.000 claims 2
- 238000006243 chemical reaction Methods 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 230000007062 hydrolysis Effects 0.000 claims 2
- 238000006460 hydrolysis reaction Methods 0.000 claims 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims 2
- 229960005181 morphine Drugs 0.000 claims 2
- 238000005580 one pot reaction Methods 0.000 claims 2
- 230000003647 oxidation Effects 0.000 claims 2
- QAEDZJGFFMLHHQ-UHFFFAOYSA-N trifluoroacetic anhydride Chemical compound FC(F)(F)C(=O)OC(=O)C(F)(F)F QAEDZJGFFMLHHQ-UHFFFAOYSA-N 0.000 claims 2
- IYXUFOCLMOXQSL-UHFFFAOYSA-N (2,2-difluoroacetyl) 2,2-difluoroacetate Chemical compound FC(F)C(=O)OC(=O)C(F)F IYXUFOCLMOXQSL-UHFFFAOYSA-N 0.000 claims 1
- PNVPNXKRAUBJGW-UHFFFAOYSA-N (2-chloroacetyl) 2-chloroacetate Chemical compound ClCC(=O)OC(=O)CCl PNVPNXKRAUBJGW-UHFFFAOYSA-N 0.000 claims 1
- KLLYGDXCCNXESW-UHFFFAOYSA-N (2-fluoroacetyl) 2-fluoroacetate Chemical compound FCC(=O)OC(=O)CF KLLYGDXCCNXESW-UHFFFAOYSA-N 0.000 claims 1
- XETRHNFRKCNWAJ-UHFFFAOYSA-N 2,2,3,3,3-pentafluoropropanoyl 2,2,3,3,3-pentafluoropropanoate Chemical compound FC(F)(F)C(F)(F)C(=O)OC(=O)C(F)(F)C(F)(F)F XETRHNFRKCNWAJ-UHFFFAOYSA-N 0.000 claims 1
- NOGFHTGYPKWWRX-UHFFFAOYSA-N 2,2,6,6-tetramethyloxan-4-one Chemical compound CC1(C)CC(=O)CC(C)(C)O1 NOGFHTGYPKWWRX-UHFFFAOYSA-N 0.000 claims 1
- PGZVFRAEAAXREB-UHFFFAOYSA-N 2,2-dimethylpropanoyl 2,2-dimethylpropanoate Chemical compound CC(C)(C)C(=O)OC(=O)C(C)(C)C PGZVFRAEAAXREB-UHFFFAOYSA-N 0.000 claims 1
- JPSKCQCQZUGWNM-UHFFFAOYSA-N 2,7-Oxepanedione Chemical compound O=C1CCCCC(=O)O1 JPSKCQCQZUGWNM-UHFFFAOYSA-N 0.000 claims 1
- IHYAGCYJVNHXCT-UHFFFAOYSA-N 3,3,4,4,5,5-hexafluorooxane-2,6-dione Chemical compound FC1(F)C(=O)OC(=O)C(F)(F)C1(F)F IHYAGCYJVNHXCT-UHFFFAOYSA-N 0.000 claims 1
- FREZLSIGWNCSOQ-UHFFFAOYSA-N 3-methylbutanoyl 3-methylbutanoate Chemical compound CC(C)CC(=O)OC(=O)CC(C)C FREZLSIGWNCSOQ-UHFFFAOYSA-N 0.000 claims 1
- HIJQFTSZBHDYKW-UHFFFAOYSA-N 4,4-dimethyloxane-2,6-dione Chemical compound CC1(C)CC(=O)OC(=O)C1 HIJQFTSZBHDYKW-UHFFFAOYSA-N 0.000 claims 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims 1
- MGICRVTUCPFQQZ-UHFFFAOYSA-N 4-methyloxane-2,6-dione Chemical compound CC1CC(=O)OC(=O)C1 MGICRVTUCPFQQZ-UHFFFAOYSA-N 0.000 claims 1
- AKHSBAVQPIRVAG-UHFFFAOYSA-N 4h-isochromene-1,3-dione Chemical compound C1=CC=C2C(=O)OC(=O)CC2=C1 AKHSBAVQPIRVAG-UHFFFAOYSA-N 0.000 claims 1
- LGRFSURHDFAFJT-UHFFFAOYSA-N Phthalic anhydride Natural products C1=CC=C2C(=O)OC(=O)C2=C1 LGRFSURHDFAFJT-UHFFFAOYSA-N 0.000 claims 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims 1
- VJDDQSBNUHLBTD-GGWOSOGESA-N [(e)-but-2-enoyl] (e)-but-2-enoate Chemical compound C\C=C\C(=O)OC(=O)\C=C\C VJDDQSBNUHLBTD-GGWOSOGESA-N 0.000 claims 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims 1
- 150000008065 acid anhydrides Chemical class 0.000 claims 1
- 238000005903 acid hydrolysis reaction Methods 0.000 claims 1
- 125000002015 acyclic group Chemical group 0.000 claims 1
- 230000010933 acylation Effects 0.000 claims 1
- 238000005917 acylation reaction Methods 0.000 claims 1
- 125000003342 alkenyl group Chemical group 0.000 claims 1
- 125000005090 alkenylcarbonyl group Chemical group 0.000 claims 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims 1
- 125000002877 alkyl aryl group Chemical group 0.000 claims 1
- 125000004448 alkyl carbonyl group Chemical group 0.000 claims 1
- 150000008064 anhydrides Chemical class 0.000 claims 1
- 125000005129 aryl carbonyl group Chemical group 0.000 claims 1
- 125000005161 aryl oxy carbonyl group Chemical group 0.000 claims 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 claims 1
- YHASWHZGWUONAO-UHFFFAOYSA-N butanoyl butanoate Chemical compound CCCC(=O)OC(=O)CCC YHASWHZGWUONAO-UHFFFAOYSA-N 0.000 claims 1
- JHIWVOJDXOSYLW-UHFFFAOYSA-N butyl 2,2-difluorocyclopropane-1-carboxylate Chemical compound CCCCOC(=O)C1CC1(F)F JHIWVOJDXOSYLW-UHFFFAOYSA-N 0.000 claims 1
- 239000003638 chemical reducing agent Substances 0.000 claims 1
- -1 cyclic organic acid Chemical class 0.000 claims 1
- ADPMHRDERZTFIN-UHFFFAOYSA-N epinastine hydrobromide Chemical compound Br.C1C2=CC=CC=C2C2CN=C(N)N2C2=CC=CC=C21 ADPMHRDERZTFIN-UHFFFAOYSA-N 0.000 claims 1
- 235000019253 formic acid Nutrition 0.000 claims 1
- VANNPISTIUFMLH-UHFFFAOYSA-N glutaric anhydride Chemical compound O=C1CCCC(=O)O1 VANNPISTIUFMLH-UHFFFAOYSA-N 0.000 claims 1
- PKHMTIRCAFTBDS-UHFFFAOYSA-N hexanoyl hexanoate Chemical compound CCCCCC(=O)OC(=O)CCCCC PKHMTIRCAFTBDS-UHFFFAOYSA-N 0.000 claims 1
- 230000003301 hydrolyzing effect Effects 0.000 claims 1
- 238000011065 in-situ storage Methods 0.000 claims 1
- LSACYLWPPQLVSM-UHFFFAOYSA-N isobutyric acid anhydride Chemical compound CC(C)C(=O)OC(=O)C(C)C LSACYLWPPQLVSM-UHFFFAOYSA-N 0.000 claims 1
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 claims 1
- DCUFMVPCXCSVNP-UHFFFAOYSA-N methacrylic anhydride Chemical compound CC(=C)C(=O)OC(=O)C(C)=C DCUFMVPCXCSVNP-UHFFFAOYSA-N 0.000 claims 1
- 230000001590 oxidative effect Effects 0.000 claims 1
- DUCKXCGALKOSJF-UHFFFAOYSA-N pentanoyl pentanoate Chemical compound CCCCC(=O)OC(=O)CCCC DUCKXCGALKOSJF-UHFFFAOYSA-N 0.000 claims 1
- ARJOQCYCJMAIFR-UHFFFAOYSA-N prop-2-enoyl prop-2-enoate Chemical compound C=CC(=O)OC(=O)C=C ARJOQCYCJMAIFR-UHFFFAOYSA-N 0.000 claims 1
- WYVAMUWZEOHJOQ-UHFFFAOYSA-N propionic anhydride Chemical compound CCC(=O)OC(=O)CC WYVAMUWZEOHJOQ-UHFFFAOYSA-N 0.000 claims 1
- 239000001632 sodium acetate Substances 0.000 claims 1
- 235000017281 sodium acetate Nutrition 0.000 claims 1
- VJDDQSBNUHLBTD-UHFFFAOYSA-N trans-crotonic acid-anhydride Natural products CC=CC(=O)OC(=O)C=CC VJDDQSBNUHLBTD-UHFFFAOYSA-N 0.000 claims 1
- 239000011541 reaction mixture Substances 0.000 description 6
- 238000004128 high performance liquid chromatography Methods 0.000 description 5
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- 239000000203 mixture Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 229950006134 normorphine Drugs 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- NFDFQCUYFHCNBW-SCGPFSFSSA-N dienestrol Chemical compound C=1C=C(O)C=CC=1\C(=C/C)\C(=C\C)\C1=CC=C(O)C=C1 NFDFQCUYFHCNBW-SCGPFSFSSA-N 0.000 description 1
- SKTCDJAMAYNROS-UHFFFAOYSA-N methoxycyclopentane Chemical compound COC1CCCC1 SKTCDJAMAYNROS-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
Description
3-O,N-ビス-エトキシカルボニル-ノルモルフィン(2.00g、4.8mmol)の無水酢酸(11.34mL、120.0mmol)中撹拌溶液に、ジメチルスルホキシド(3.41mL、48.0mmol)を窒素の不活性雰囲気下で一度に添加し、得られた混合物を80℃で1.5時間撹拌し、その時点でHPLC分析により反応混合物中で<2%の式(III)の化合物が検出された。次いで、トリエチルアミン(6.69mL、48.0mmol)を反応混合物に一度に添加し、80℃で2.5時間撹拌し、その時点でHPLC分析により反応混合物中で<2%の式(IV)の化合物が検出された。反応混合物を室温に冷却し、水(50mL)で希釈し、シクロペンチルメチルエーテル(3×50mL)で抽出した。合わせた有機抽出物を飽和重炭酸ナトリウム水溶液(3×25mL)、水(25mL)で洗浄し、硫酸マグネシウムで乾燥させて真空中で濃縮すると、得られた表題化合物のHPLC分析により決定して96.27%の純度を有する表題化合物2.04g(理論値の93%)が残った。
実施例13a:ステップ3a:過酢酸を用いた式(VI)の化合物の調製:
3-O,N-ビス-エトキシカルボニル-14-ノルモルフィノン(R
1
及びR
2
=エトキシカルボニルを有する化合物VI)
無水酢酸(15mL、120.0mmol)中の3-O,N-ビス-エトキシカルボニル-ノルモルフィンジエノールアセテート(5.0g、11.0mmol)の撹拌溶液に、50%H
2
O
2
水溶液(8.10mL、114mmol)を、不活性窒素雰囲気下で一度に添加し、得られた混合物を40℃で4時間撹拌し、その時点でHPLC分析により反応混合物中で<2%の式(V)の化合物が検出された。反応混合物を室温に冷却し、水(50mL)で希釈し、2Mアンモニア水溶液(72mL)の添加により、pHをゆっくりと8まで調整した。混合物をクロロホルム(3×60mL)で抽出した。合わせた有機抽出物をブライン(75mL)で洗浄し、硫酸マグネシウムで乾燥させて真空中で濃縮すると、得られた表題化合物のHPLC分析により決定して92.31%の純度を有する表題化合物4.60g(理論値の98%)が残った。
To a stirred solution of 3-O,N-bis-ethoxycarbonyl-normorphine (2.00 g, 4.8 mmol) in acetic anhydride (11.34 mL, 120.0 mmol) was added dimethyl sulfoxide (3.41 mL, 48.0 mmol). was added in one portion under an inert atmosphere of nitrogen and the resulting mixture was stirred at 80° C. for 1.5 h, at which point <2% of the compound of formula (III) was detected in the reaction mixture by HPLC analysis. It was done. Triethylamine (6.69 mL, 48.0 mmol) was then added to the reaction mixture in one portion and stirred at 80° C. for 2.5 h, at which point there was <2% of formula (IV) in the reaction mixture by HPLC analysis. Compound detected. The reaction mixture was cooled to room temperature, diluted with water (50 mL), and extracted with cyclopentyl methyl ether (3 x 50 mL). The combined organic extracts were washed with saturated aqueous sodium bicarbonate (3 x 25 mL), water (25 mL), dried over magnesium sulfate and concentrated in vacuo to yield a 96% title compound as determined by HPLC analysis. 2.04 g (93% of theory) of the title compound remained with a purity of .27%.
Example 13a: Step 3a: Preparation of compound of formula (VI) using peracetic acid:
3-O,N-bis-ethoxycarbonyl-14-normorphinone (compound VI with R 1 and R 2 =ethoxycarbonyl)
To a stirred solution of 3-O,N-bis-ethoxycarbonyl-normorphine dienol acetate (5.0 g, 11.0 mmol) in acetic anhydride (15 mL, 120.0 mmol) was added 50% aqueous H 2 O ( 8 .10 mL, 114 mmol) was added in one portion under an inert nitrogen atmosphere and the resulting mixture was stirred at 40 °C for 4 h, at which point <2% of formula (V) was found in the reaction mixture by HPLC analysis. Compound detected. The reaction mixture was cooled to room temperature, diluted with water (50 mL), and the pH was slowly adjusted to 8 by addition of 2M aqueous ammonia (72 mL). The mixture was extracted with chloroform (3 x 60 mL). The combined organic extracts were washed with brine (75 mL), dried over magnesium sulfate and concentrated in vacuo to yield the title compound 4. with a purity of 92.31% as determined by HPLC analysis of the title compound. 60 g (98% of theory) remained.
Claims (17)
1)式(II)のモルヒネを反応させて式(III)の化合物を得るステップ、
2a)前記式(III)の化合物を酸化剤で酸化して式(IV)の化合物を得るステップ、
2b)前記式(IV)の化合物をアシル化剤でアシル化して式(V)の化合物を得るステップ、
3a)前記式(V)の化合物をペルオキシ酸化に供して式(VI)の化合物を得るステップ、
3b)前記式(VI)の化合物を還元して式(VII)の化合物を得るステップ、及び
4)前記式(VII)の化合物を加水分解して式(I)のノルオキシモルフォンを得るステップを含み、
式中、R1及びR2は、独立して1~20個の炭素原子を有する置換若しくは非置換アルキル基、又は置換若しくは非置換アリール基、又は1~20個の炭素原子を有する置換若しくは非置換アルキルアリール基、又は2~20個の炭素原子を有する置換若しくは非置換アルケニル基、又はアルキル残基中に1~20個の炭素原子を有する置換若しくは非置換アルコキシカルボニル基、又は置換若しくは非置換アリールオキシカルボニル基、又はアルキル残基中に1~20個の炭素原子を有する置換若しくは非置換アルキルアリールオキシカルボニル基、又はシアニド基、又は式Si(R4)3(式中、基R4は同一又は異なっていてもよく、それぞれ1~6個の炭素原子を有する置換若しくは非置換アルキル基及び置換若しくは非置換アリール基からそれぞれ選択され、R3は、それぞれアルキル残基中に1~20個の炭素原子を有する置換若しくは非置換アルキルカルボニル基、又はアルキル残基中に1~20個の炭素原子を有する置換若しくは非置換アルキルアリールカルボニル基、又は置換若しくは非置換アリールカルボニル基、又は2~20個の炭素原子を有する置換若しくは非置換アルケニルカルボニル基である)のシリル基であり、
ステップ2aがAlbright-Goldman酸化条件を使用して行われ、
ステップ2a及びステップ2bをワンポット単一ステップ変換に組み合わせることができ、
ステップ3a及びステップ3bをワンポット単一ステップ変換に組み合わせることができる、方法。 A method for preparing noroxymorphone from morphine, comprising:
1) reacting morphine of formula (II) to obtain a compound of formula (III);
2a) oxidizing the compound of formula (III) with an oxidizing agent to obtain a compound of formula (IV);
2b) acylating the compound of formula (IV) with an acylating agent to obtain a compound of formula (V);
3a) subjecting the compound of formula (V) to peroxyoxidation to obtain a compound of formula (VI);
3b) reducing the compound of formula (VI) to obtain a compound of formula (VII); and 4) hydrolyzing the compound of formula (VII) to obtain noroxymorphone of formula (I). including,
In the formula, R 1 and R 2 are independently a substituted or unsubstituted alkyl group having 1 to 20 carbon atoms, or a substituted or unsubstituted aryl group having 1 to 20 carbon atoms, or a substituted or unsubstituted aryl group having 1 to 20 carbon atoms. Substituted alkylaryl groups, or substituted or unsubstituted alkenyl groups having 2 to 20 carbon atoms, or substituted or unsubstituted alkoxycarbonyl groups having 1 to 20 carbon atoms in the alkyl residue, or substituted or unsubstituted An aryloxycarbonyl group, or a substituted or unsubstituted alkylaryloxycarbonyl group having 1 to 20 carbon atoms in the alkyl residue, or a cyanide group, or a cyanide group, or a group of the formula Si(R 4 ) 3 (wherein the group R 4 is R 3 is selected from substituted or unsubstituted alkyl groups and substituted or unsubstituted aryl groups each having 1 to 6 carbon atoms, which may be the same or different, and each R 3 is selected from 1 to 20 carbon atoms in the alkyl residue. a substituted or unsubstituted alkylcarbonyl group having from 1 to 20 carbon atoms in the alkyl residue, or a substituted or unsubstituted arylcarbonyl group having from 1 to 20 carbon atoms in the alkyl residue; a substituted or unsubstituted alkenylcarbonyl group having 5 carbon atoms;
step 2a is performed using Albright-Goldman oxidation conditions;
Step 2a and step 2b can be combined into a one-pot single-step conversion,
A method in which step 3a and step 3b can be combined into a one-pot single-step conversion.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN202021056621 | 2020-12-28 | ||
IN202021056621 | 2020-12-28 | ||
PCT/IN2021/050262 WO2022144911A1 (en) | 2020-12-28 | 2021-03-15 | Novel process for the synthesis of noroxymorphone from morphine |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2024501153A JP2024501153A (en) | 2024-01-11 |
JPWO2022144911A5 true JPWO2022144911A5 (en) | 2024-03-04 |
Family
ID=82260596
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2023533312A Pending JP2024501153A (en) | 2020-12-28 | 2021-03-15 | A novel method for the synthesis of noroxymorphone from morphine |
Country Status (8)
Country | Link |
---|---|
US (1) | US20230357257A1 (en) |
EP (1) | EP4267583A1 (en) |
JP (1) | JP2024501153A (en) |
KR (1) | KR20230127222A9 (en) |
AU (1) | AU2021416361A1 (en) |
BR (1) | BR112023012708A2 (en) |
CA (1) | CA3200832A1 (en) |
WO (1) | WO2022144911A1 (en) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2562072B1 (en) * | 1984-03-27 | 1989-07-07 | Mallinckrodt Inc | PROCESS FOR THE PREPARATION OF NOROXYMORPHONE FROM MORPHINE, AND INTERMEDIATE COMPOUNDS USED IN THIS PROCESS |
EP2829541A1 (en) * | 2013-07-26 | 2015-01-28 | Siegfried AG | Novel synthesis of noroxymorphone from morphine |
-
2021
- 2021-03-15 BR BR112023012708A patent/BR112023012708A2/en unknown
- 2021-03-15 EP EP21914889.7A patent/EP4267583A1/en active Pending
- 2021-03-15 JP JP2023533312A patent/JP2024501153A/en active Pending
- 2021-03-15 WO PCT/IN2021/050262 patent/WO2022144911A1/en active Application Filing
- 2021-03-15 CA CA3200832A patent/CA3200832A1/en active Pending
- 2021-03-15 KR KR1020237021531A patent/KR20230127222A9/en active Search and Examination
- 2021-03-15 AU AU2021416361A patent/AU2021416361A1/en active Pending
-
2023
- 2023-06-27 US US18/342,381 patent/US20230357257A1/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103880903B (en) | A kind of preparation method of tylosin class macrolide and derivant thereof | |
US4425273A (en) | Process for production of chenodeoxycholic acid | |
CN108503531B (en) | Preparation method of 3, 3-dimethyl-2-oxobutyric acid | |
Kitamura et al. | Pd (II)-catalyzed formal O–H insertion reactions of diazonaphthoquinones to acetic acid: synthesis of 1, 2-naphthalenediol derivatives | |
CN113698331A (en) | Synthetic method of L-selenium-methyl selenocysteine | |
JP4327248B2 (en) | New derivatives of 5-O-deosaminyl-6-O-methylerythronolide A, processes for their preparation and their use in the production of biologically active substances | |
WO2008069440A1 (en) | The preparation method of 2-de0xy-l-rib0se | |
EP1765848B8 (en) | Process for the preparation of 4-azasteroids | |
JPH0150704B2 (en) | ||
US8039626B2 (en) | Method of manufacturing of 7-ethyl-10-hydroxycamptothecin | |
JPWO2022144911A5 (en) | ||
EP1503983B1 (en) | A process for the preparation of modafinil | |
EP0003643A1 (en) | Process for the preparation of 4-(6-methoxy-2-naphthyl)-butan-2-one; 4-(6-methoxy-2-naphthyl)-4-hydroxybut-3-en-2-one and a process for its preparation | |
EP1940770B1 (en) | Novel method for preparing unsaturated fatty hydroxyacids | |
JPH049349A (en) | Production of 3-phenoxypropanal compound | |
JP2024501153A (en) | A novel method for the synthesis of noroxymorphone from morphine | |
Lee et al. | A practical and stereoselective synthesis of cinnamyl alcohols bearing α-cyano or α-ester functional group from Baylis-Hillman adducts | |
JP2001011026A (en) | Production of 3-methyl-4-nitrobenzoic acid | |
US5405978A (en) | Oxidative preparation of 3,5-secoandrost-5-one-3,17 β-dioic acid | |
JPH0124782B2 (en) | ||
JP3063175B2 (en) | Method for producing 4-hydroxycyclopentenones | |
KR100271294B1 (en) | Process for the preparation of 2-[(2,6-dichlorophenyl)amino]phenylacetoxy acetic acid | |
KR20220168271A (en) | Novel preparing method for regioselective 1,5-dimethyltetrazole | |
KR100470975B1 (en) | Efficient methods for preparing agi-7 and sescandelin | |
CA1066291A (en) | 3-formyl-4-methyl-2,6-dihydroxypyridine and a process for its preparation |